# A Study to Assess the Safety and Efficacy of a New Influenza Candidate Vaccine MVA-NP+M1 In Healthy Adults

> **NCT00993083** · PHASE2 · COMPLETED · sponsor: **University of Oxford** · enrollment: 27 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** MVA-NP+M1

## Key facts

- **NCT ID:** NCT00993083
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2011-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00993083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00993083, "A Study to Assess the Safety and Efficacy of a New Influenza Candidate Vaccine MVA-NP+M1 In Healthy Adults". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00993083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*